Cabot (CBT) Q3 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure · Editorial policy
Key numbers
- Adjusted EPS
- $1.61
- Estimate
- $1.54
- Surprise
- +4.6%
- Score at report (before → after)
- 6.2 → 6.1/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Cabot (CBT) beat the $1.54 estimate with adjusted EPS of $1.61 — a clear 4.6% upside surprise. TrendMatrix's engine moved from Buy (Wait) (6.2/10) to Hold at 6.1/10 after the report — the engine's score fell despite the beat.
Coverage in the report window
- Cabot Sees FY2027 Adj EPS $6.15-$6.75 vs $7.01 Est — benzinga, 2026-11-02
Where TrendMatrix's rating stands now
TrendMatrix currently rates CBT Hold at 6.1/10.
4 of the last 4 quarters beat the estimate; this quarter's +4.6% surprise compares with a +6.5% four-quarter average.
What supports the rating
- Strong earnings beat streak (4/4)
- Attractive valuation
What argues against it
- Thin upside margin: 3.8%
- V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)
- Sector modifier (Basic Materials): -0.1
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $75.72
- Price target
- $78.59
- Stop
- $72.62
- Upside to target
- +3.8%
- Reward-to-risk
- 0.8:1
The stock trades at 20.9× trailing but 9.9× forward earnings — consensus estimates already build in a substantial earnings recovery.
Risk check: trading volume is running 1.6× its average — elevated turnover around the report window.
Model outputs from TrendMatrix’s engine as of 2026-11-03 — shown for context, not personalized investment advice.
CBT at TrendMatrix's latest read
Materials producers report against the commodity cycle — realized-price capture and volume, not the EPS line, are the tells in a quarter like this.
- Industry
- Specialty Chemicals
- Market cap
- $3.91B
- P/E (fwd)
- 9.9
- P/E (ttm)
- 20.9
- 52-week range
- $58.33–$94.53
- Off 52-week high
- 19.9%
- RSI (14)
- 52
- Volume vs avg
- 1.62×
- Score today
- 6.1/10